A hormone that reverses obesity in mice appears to work by signaling to a brain region involved in metabolism and appetite regulation, the same area targeted by the popular GLP-1 drugs. The finding, from University of Oklahoma researchers, is published in Cell Reports.

Cheers and happy tears filled campuses in Oklahoma City and Tulsa as 161 members of the OU College of Medicine Class of 2026 learned where they will be training for their residencies. The occasion was Match Day, a pivotal milestone that helps shape the future of the state’s health care workforce.

When people cannot hear their own voices, their tongue movements become less precise when they speak, according to a study from the University of Oklahoma. This finding, the first direct evidence of its kind, could help guide therapies designed to restore speech control in people with hearing loss or those whose tongues have been affected by cancer.

A powerful new $16 million cyclotron is arriving soon at the University of Oklahoma College of Pharmacy, marking a major expansion of advanced medical imaging, cancer treatment and research capabilities for patients across the state.

For the millions of people living with lupus – a chronic autoimmune disease that can damage the kidneys, brain and other vital organs – treatment options remain limited and often come with serious side effects. A $1.7 million grant from the National Institutes of Health will allow a University of Oklahoma researcher to continue investigating a protein that may help explain why the disease develops and how it might be treated more precisely.